Latest Sanofi Press Releases and News | Sanofi
Sep 26, 2024 · Stay informed with the latest Sanofi press releases and news updates. Discover new developments in healthcare and pharmaceuticals with Sanofi.
Sanofi in exclusive talks with CD&R over sale of $17 billion Opella
4 days ago · French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & Rice (CD&R).
Sanofi reaches deal on terms of sale of consumer health arm, say …
4 days ago · PARIS (Reuters) -Sanofi on Sunday reached an agreement on terms to sell a controlling stake in its consumer health unit Opella to U.S. private equity firm Clayton Dubilier & Rice (CD&R), French ...
Sanofi in 'exclusive negotiations' to sell 50% stake in €16B …
3 days ago · Sanofi is now in “exclusive negotiations” with U.S. private equity firm Clayton, Dubilier & Rice (CD&R) to sell a 50% controlling stake in its consumer health business Opella.. With the French ...
Sanofi Enters Exclusive Talks With CD&R Over Consumer Business …
3 days ago · Sanofi moved ahead with a plan to sell a controlling stake in its consumer-healthcare unit Opella to Clayton Dubilier & Rice, entering exclusive talks for a deal that values the business at $17.4 ...
Live news: Sanofi enters exclusive talks on €16bn consumer …
5 days ago · France’s Sanofi is pursuing an offer from US private equity group Clayton, Dubilier & Rice for control of its consumer healthcare division despite a political backlash, confirming on Monday the ...
Sanofi US News
Sep 27, 2024 · Sanofi and Regeneron are motivated to transform the treatment paradigm of COPD by examining the role different types of inflammation play in the disease progression through Dupixent, a first-in-class biologic, and the investigation of itepekimab.
Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions …
4 days ago · Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare. Sanofi and CD&R enter exclusive negotiations to transfer a 50% controlling stake in Opella with Sanofi to remain a significant shareholder ; With 11,000 talented and passionate people bringing iconic brands to life, Opella poised to ignite new bold development journey
Sanofi pushes ahead with €20bn consumer healthcare spin-off
Jun 2, 2024 · Sanofi will press ahead with plans for a spin-off of its consumer division, which could be one of Europe’s biggest deals this year, adding bankers to work on a sale process and preparations for a...
Sanofi US News
May 22, 2024 · Encouraging results from a phase 2 study showed that treatment with oral rilzabrutinib at both high dose and low doses led to a numerical reduction in loss of asthma control (LOAC) events (the primary endpoint) and improvements in symptoms in adult patients with uncontrolled moderate-to-severe asthma.